BioSpace News Archive

Biohaven Pharmaceutical Holding Company Ltd. announced that it has received a Complete Response Letter from the FDA for the 5052 application seeking approval for NURTEC™ for ALS.

Khrysos Industries Expects Shipping under the One Year Agreement to begin in August 2019

Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets.

For the past twelve years, Canon Medical Systems USA, Inc. has partnered with AHRA: The Association for Medical Imaging Management in support of the Putting Patients First program, awarding grants dedicated to improving patient care and developing best imaging practices in the areas of CT, MR, Ultrasound, X-ray and Vascular.

Findings from a study published today in Lupus Science & Medicine™ provide an actionable framework to advance the lupus field, which has seen many failed clinical trials, variations in care and poor access to care worldwide.

High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases.

Trillium Community Health Plan (Trillium) is pleased to announce the appointment of Christopher Hummer as the new CEO of Trillium and Health Net of Oregon, effective August 12, 2019.

The costs and timelines to conduct clinical trials continue to increase, as does study complexity.

The number of women using cannabis in the year before they get pregnant and early in their pregnancies is increasing, and their frequency of use is also rising, according to new data from Kaiser Permanente.

The NRP Group, a vertically-integrated, best-in-class developer, builder and manager of multifamily housing, today announced it will partner with The MetroHealth System and CCH Development Corp. to develop a mixed-use community in Cleveland’s Clark-Fulton neighborhood.